Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution P Eirew, A Steif, J Khattra, G Ha, D Yap, H Farahani, K Gelmon, S Chia, ... Nature 518 (7539), 422-426, 2015 | 654 | 2015 |
A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds A Bruna, OM Rueda, W Greenwood, AS Batra, M Callari, RN Batra, ... Cell 167 (1), 260-274. e22, 2016 | 445 | 2016 |
Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing E Laks, A McPherson, H Zahn, D Lai, A Steif, J Brimhall, J Biele, B Wang, ... Cell 179 (5), 1207-1221. e22, 2019 | 180 | 2019 |
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ... EMBO molecular medicine 3 (3), 167-180, 2011 | 142 | 2011 |
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer A Bruna, W Greenwood, J Le Quesne, A Teschendorff, ... Nature communications 3 (1), 1055, 2012 | 127 | 2012 |
Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts M Callari, AS Batra, RN Batra, SJ Sammut, W Greenwood, H Clifford, ... BMC genomics 19, 1-12, 2018 | 58 | 2018 |
Context-specific effects of TGF-β/SMAD3 in cancer are modulated by the epigenome AT Vidakovic, OM Rueda, SJ Vervoort, AS Batra, MA Goldgraben, ... Cell reports 13 (11), 2480-2490, 2015 | 56 | 2015 |
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response D Georgopoulou, M Callari, OM Rueda, A Shea, A Martin, A Giovannetti, ... Nature communications 12 (1), 1998, 2021 | 45 | 2021 |
Patient-derived tumour xenografts for breast cancer drug discovery JW Cassidy, AS Batra, W Greenwood, A Bruna Endocrine-related cancer 23 (12), T259-T270, 2016 | 21 | 2016 |
Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer P Kreuzaler, P Inglese, A Ghanate, E Gjelaj, V Wu, Y Panina, ... Nature Metabolism 5 (11), 1870-1886, 2023 | 8 | 2023 |
TGF-β and the SMAD Signaling Pathway in Carcinogenesis W Greenwood, A Bruna Predictive Biomarkers in Oncology: Applications in Precision Medicine, 305-310, 2019 | 3 | 2019 |
Fingolimod: Assay analysis of US generic capsule products reveals variation in fingolimod content beyond the recommended acceptance criteria C Wainwright, S Fuller, V Dickinson, W Greenwood Multiple Sclerosis and Related Disorders 80, 105077, 2023 | 1 | 2023 |
TGF-β and the SMAD Signaling W Greenwood, A Bruna Predictive Biomarkers in Oncology: Applications in Precision Medicine, 305, 2018 | 1 | 2018 |
Author's addendum to the article: Fingolimod: Assay analysis of US generic capsule products reveals variation in fingolimod content beyond the recommended acceptance criteria W Greenwood, V Dickinson, S Fuller, C Wainwright Multiple Sclerosis and Related Disorders 82, 105393, 2024 | | 2024 |
Modelling drug responses and evolutionary dynamics using triple negative breast cancer patient-derived xenografts A Shea, Y Eyal-Lubling, D Guerrero-Romero, RM Garcia, W Greenwood, ... bioRxiv, 2023.01. 10.523259, 2023 | | 2023 |
The role of NEDD9 in TGFβ mediated tumour initiating cell dynamics in the Claudin-low breast cancer subtype W Greenwood | | 2021 |
Metabolic heterogeneity in breast cancer integrative clusters to screen metabolic vulnerabilities for diagnosis and treatment response S Ros, AJ Wright, F Bulat, W Greenwood, D Hu, M Callari, ML Chia, ... Cancer Research 81 (13_Supplement), 2817-2817, 2021 | | 2021 |
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response. D Georgopoulou, M Callari, O Rueda Palacio, A Shea, A Martin, ... Springer Science and Business Media LLC, 2021 | | 2021 |
PO-491 Single-cell phenotypic profiling of breast cancerpatient-derived tumour xenografts using mass cytometry D Georgopoulou, M Callari, A Martin, OM Rueda, W Greenwood, ... ESMO Open 3, A214, 2018 | | 2018 |
Integrative analysis of molecular and drug response data from clinical samples and PDTXs to identify pharmacogenomic associations in breast cancer M Callari, RN Batra, AS Batra, W Greenwood, SF Chin, A Bruna, ... Cancer Research 77 (13_Supplement), 2991-2991, 2017 | | 2017 |